Callan Jmb Inc.
CJMB Nasdaq Services-Business Services, Nec Financials FY2023–FY2025
Last close · Oct 23, 2026
$0.57
10.2%What Callan Jmb Inc. does
No business description yet.
- Legal name
- CALLAN JMB INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 31, 2026
- Accession · CIK
- 0001493152-26-014292
0002032545
Revenue and margins
Callan Jmb Inc. had $5.7M of revenue in fiscal 2025, down 12.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$5.2M in fiscal 2025, −90.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Callan Jmb Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 66.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Callan Jmb Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $5.2M | $2.1M | $2.1M |
| Debt incl. finance leases | $0.0M | $0.0M | — |
| Net debt / EBITDA | −2.2x | — | — |
| Debt / equity | 0.0x | 0.0x | — |
| Interest coverage | 271.9x | −421.3x | −2,605.4x |
| Current ratio | 11.0x | 2.6x | 2.2x |
| Quick ratio | 10.8x | 2.5x | 2.0x |
| Total assets | $9.7M | $5.1M | $5.8M |
| Total liabilities | $0.9M | $1.9M | $3.4M |
| Shareholders' equity | $8.8M | $3.2M | $2.3M |
| Net debt (− = net cash) | −$5.1M | −$2.1M | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✓ | ✕ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✕ |
| Return on assets rose | — | ✕ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | ✓ | — |
| Current ratio rose | — | ✕ | ✕ |
| Share count didn't rise | — | — | ✕ |
| Gross margin rose | — | ✕ | ✕ |
| Revenue rose relative to assets | — | ✕ | ✕ |
| F-score | — / 3 | 3 / 8 | 1 / 8 |
| Accruals ratio | −49.6% | −38.3% | −63.0% |
| Altman Z'' | — | −0.09 | −11.40 |
3 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $13.2M | $6.6M | $5.7M |
| Gross profit | $5.6M | $2.6M | $2.1M |
| Operating income | $2.2M | −$2.3M | −$7.0M |
| Interest expense | $0.0M | $0.0M | $0.0M |
| Pretax income | $2.2M | −$2.3M | −$8.0M |
| Income tax | $0.0M | $0.0M | −$0.0M |
| Net income | $2.2M | −$2.3M | −$8.0M |
| Diluted EPS | — | −$0.87 | −$1.82 |
| Diluted shares | — | 0.00B | 0.00B |
| Cash flow | |||
| Cash from operations | $7.0M | $0.5M | −$4.5M |
| Capital expenditure | $0.5M | $0.0M | $0.6M |
| Free cash flow | $6.5M | $0.5M | −$5.2M |
| Depreciation and amortization | $0.1M | $0.1M | $0.2M |
| Stock-based compensation | — | — | $1.6M |
| Dividends paid | $7.4M | $3.3M | — |
| Dividends and buybacks | $7.4M | $3.3M | — |
| Balance sheet | |||
| Cash and short-term investments | $5.2M | $2.1M | $2.1M |
| Total debt | $0.0M | $0.0M | — |
| Current assets | $8.5M | $3.3M | $3.1M |
| Current liabilities | $0.8M | $1.3M | $1.4M |
| Inventory | $0.1M | $0.2M | $0.2M |
| Property and equipment, net | $1.0M | $0.9M | $0.8M |
| Total assets | $9.7M | $5.1M | $5.8M |
| Total liabilities | $0.9M | $1.9M | $3.4M |
| Shareholders' equity | $8.8M | $3.2M | $2.3M |
| Margins | |||
| Gross margin | 42.8% | 39.1% | 36.8% |
| Operating margin | 16.7% | −34.7% | −122.9% |
| EBITDA margin | 17.5% | −32.5% | −120.3% |
| Net margin | 16.5% | −34.9% | −139.2% |
| FCF margin | 49.3% | 7.5% | −90.2% |
| Returns | |||
| Return on capital | 59.6% | −167.1% | — |
| Return on capital employed | 24.6% | −59.7% | −161.3% |
| Return on equity | 24.8% | −38.3% | −289.6% |
| Return on assets | 22.5% | −31.0% | −146.7% |
| Return on tangible equity | 24.8% | −72.3% | −342.2% |
| Growth | |||
| Revenue growth | — | −50.3% | −12.8% |
| Net income growth | — | −205.2% | — |
| FCF growth | — | −92.4% | −1,144.8% |
| Share count change | — | — | 66.5% |
| Financial health | |||
| Net debt / EBITDA | −2.2x | — | — |
| Debt / equity | 0.0x | 0.0x | — |
| Interest coverage | 271.9x | −421.3x | −2,605.4x |
| Current ratio | 11.0x | 2.6x | 2.2x |
| Quick ratio | 10.8x | 2.5x | 2.0x |
| Capital allocation | |||
| Capex / revenue | 3.7% | 0.7% | 10.8% |
| Stock comp / revenue | — | — | 27.3% |
| Payouts / FCF | 113.7% | 673.5% | — |
| Quality scores | |||
| Piotroski F-score | — | 3.0 | 1.0 |
| Altman Z'' | — | −0.1 | −11.4 |
| Accruals ratio | −49.6% | −38.3% | −63.0% |
Source: SEC EDGAR XBRL filings (CIK 0002032545). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
